ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
3.13
-0.06 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
3.13
-0.04%
After-hours: Aug 15, 2025, 06:42 PM EDT
ADC Therapeutics S.A. Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -38.6M | -30.73M | -43.97M | -36.54M | -46.61M | -85.7M | -47.81M | -47.12M | -59.43M | -24.16M | -50.61M | -64.37M | -16.66M | -34.38M | -71.55M | -72.57M | -51.53M |
Depreciation & Amortization | 801K | 793K | 802K | 838K | 843K | 1.01M | 793K | 769K | 694K | 576K | 572K | 586K | 594K | 759K | 658K | 635K | 578K |
Stock-Based Compensation | 2.42M | 1.62M | 2.81M | 1.99M | 158K | 1.55M | 2.51M | 1.36M | 8.07M | 7.54M | 14.56M | 13.82M | 13.4M | 13.46M | 14.8M | 18.27M | 13.95M |
Other Working Capital | n/a | 5.43M | 3.91M | -640.87K | -10.1M | 7.94M | 1.66M | 866K | -11.45M | 8.51M | 1.01M | 17.93M | -9.04M | 5.06M | 3.89M | 499K | -4.26M |
Other Non-Cash Items | n/a | -3.56M | 6.78M | 14.31M | 13.1M | -5.86M | 10.84M | 15.37M | 2.88M | 383K | 41.88M | -15.38M | -25.81M | -9.92M | 11.21M | -6.07M | -19.91M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 45.75M | -578K | -7.22M | -848K | 6.84M | 441K | -4.13M | -3.86M | -21.97M | 145K | 240K | 107K |
Change in Working Capital | n/a | 10.03M | 8.54M | -4.58M | -9.92M | 10.18M | 224K | 251K | 33.62M | -43.28M | -4.65M | 16.47M | -1.55M | -9.58M | -13.85M | 1.49M | 1.66M |
Operating Cash Flow | -56.33M | -21.85M | -25.04M | -31.58M | -44.09M | -33.07M | -34.02M | -36.83M | -14.77M | -52.1M | 2.19M | -53.01M | -33.88M | -61.63M | -58.59M | -58.01M | -55.15M |
Capital Expenditures | -264K | -90K | -216K | -20.8K | -531K | -327K | -661K | -1.21M | -1.02M | -117K | -254K | -809K | -1.12M | -533K | -2.34M | -2.85M | -657K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -200K | 2.01K | 200K | -20K | -1.95K | -595.3 | 120K | -330K | -297K | -933K | -1.9M | n/a |
Investing Cash Flow | -264K | -90K | -216K | -20.8K | -531K | -527K | -661K | -1.01M | -1.02M | -117K | -254K | -689K | -1.45M | -830K | -2.34M | -2.85M | -657K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -409K | n/a | n/a | -1.93M | 114.24M | n/a | -258K | -231K | -229K | 49.37M | -300K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -218.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 271K | -1.12M | 346K | 98.7M | 356K | 1.64M | -1.21M | 73.1M | 425K | -238.55K | -111.88M | -252K | n/a | -987K | 219.53M | 231K | 3K |
Financial Cash Flow | 271K | -1.12M | -879K | 97.07M | 356K | 1.64M | -2.31M | 74.74M | -196K | -2.45M | 2.37M | -252K | -258K | -1.22M | 219.3M | 49.6M | -297K |
Net Cash Flow | -56.17M | -23.41M | -25.85M | 65.83M | -44.31M | -31.81M | -37.1M | 36.96M | -15.89M | -54.42M | 4.08M | -54.1M | -35.67M | -63.65M | 158.31M | -11.24M | -56.07M |
Free Cash Flow | -56.6M | -21.94M | -25.26M | -31.6M | -44.63M | -33.4M | -34.68M | -38.04M | -15.79M | -52.21M | 1.94M | -53.82M | -35M | -62.16M | -60.93M | -60.86M | -55.81M |